4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-17-002695
CIK 0000827871operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:15 PM ET
Size
5.4 KB
Accession
0001209191-17-002695
Insider Transaction Report
Form 4
Glenning Robert
Director
Transactions
- Award
Stock Option (right to buy)
2017-01-04+10,000→ 10,000 totalExercise: $84.92Exp: 2027-01-03→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option fully vests on January 4, 2018, subject to the reporting person's continuous service with the issuer as of the vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:15 PM ET
- Size
- 5.4 KB